Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Francesco Muratore, Nicolò Pipitone & Carlo Salvarani. (2017) Standard and biological treatment in large vessel vasculitis: guidelines and current approaches. Expert Review of Clinical Immunology 13:4, pages 345-360.
Read now
Read now
Enrico Tombetti, Angelo Manfredi, Maria Grazia Sabbadini & Elena Baldissera. (2013) Management options for Takayasu arteritis. Expert Opinion on Orphan Drugs 1:9, pages 685-693.
Read now
Read now
Articles from other publishers (60)
Alexandre Wagner S. de Souza, Emilia I. Sato, Maria Lorena Brance, Daniel G. Fernández-Ávila, Marina Scolnik, Sebastián Juan Magri, Manuel Francisco Ugarte-Gil, Luis Felipe Flores-Suárez, Lina María Saldarriaga-Rivera, Alejandra Babini, Natalia V. Zamora, María Laura Acosta Felquer, Facundo Vergara, Leandro Carlevaris, Santiago Scarafia, Enrique Roberto Soriano Guppy & Sebastian Unizony. (2023) Pan American League of Associations for Rheumatology Guidelines for the Treatment of Takayasu Arteritis. JCR: Journal of Clinical Rheumatology.
Crossref
Crossref
Chandhu AS & Debashish Danda. (2023) Current Diagnosis and Management of Takayasu Arteritis. International Heart Journal 64:4, pages 519-534.
Crossref
Crossref
Franz Felix Konen, Nora Möhn, Torsten Witte, Matthias Schefzyk, Miriam Wiestler, Svjetlana Lovric, Karsten Hufendiek, Philipp Schwenkenbecher, Kurt-Wolfram Sühs, Manuel A. Friese, Luisa Klotz, Refik Pul, Marc Pawlitzki, David Hagin, Christoph Kleinschnitz, Sven G. Meuth & Thomas Skripuletz. (2023) Treatment of autoimmunity: The impact of disease-modifying therapies in multiple sclerosis and comorbid autoimmune disorders. Autoimmunity Reviews 22:5, pages 103312.
Crossref
Crossref
Javier Narváez, Paula Estrada, Dídac LLop, Paola Vidal-Montal, Emma Brugarolas, Pol Maymó-Paituvi, Judith Palacios-Olid & Joan Miquel Nolla. (2023) Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies. Seminars in Arthritis and Rheumatism 59, pages 152166.
Crossref
Crossref
Ying Sun, Bingjie Wu, Wei Zhang, Lili Ma, Xiufang Kong, Huiyong Chen & Lindi Jiang. (2023) Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC). Therapeutic Advances in Chronic Disease 14, pages 204062232311585.
Crossref
Crossref
David S. Younger. 2023. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders
653
705
.
Durga Prasanna Misra, Alessandro Tomelleri, Upendra Rathore, Giovanni Benanti, Kritika Singh, Manas Ranjan Behera, Neeraj Jain, Manish Ora, Dharmendra Singh Bhadauria, Sanjay Gambhir, Sudeep Kumar, Elena Baldissera, Vikas Agarwal, Corrado Campochiaro & Lorenzo Dagna. (2022) Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India. Diagnostics 12:12, pages 3102.
Crossref
Crossref
Debashish Danda, Prathyusha Manikuppam, Xinping Tian & Masayoshi Harigai. (2022) Advances in Takayasu arteritis: An Asia Pacific perspective. Frontiers in Medicine 9.
Crossref
Crossref
Sinem Nihal Esatoglu & Gulen Hatemi. (2022) Takayasu arteritis. Current Opinion in Rheumatology 34:1, pages 18-24.
Crossref
Crossref
Durga Prasanna Misra, Upendra Rathore, Pallavi Patro, Vikas Agarwal & Aman Sharma. (2021) Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis—a systematic review and meta-analysis. Clinical Rheumatology 40:11, pages 4391-4416.
Crossref
Crossref
Fatma Alibaz-Oner & Haner Direskeneli. 2021. Large and Medium Size Vessel and Single Organ Vasculitis. Large and Medium Size Vessel and Single Organ Vasculitis
131
143
.
Yiwen Wang, Zheng Zhao, Dai Gao, Hui Wang, Simin Liao, Chongya Dong, Gui Luo, Xiaojian Ji, Yan Li, Xiuru Wang, Yurong Zhao, Kunpeng Li, Jie Zhang, Jingyu Jin, Yamei Zhang, Jian Zhu, Jianglin Zhang & Feng Huang. (2020) Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial. Seminars in Arthritis and Rheumatism 50:6, pages 1513-1520.
Crossref
Crossref
J. H. Schirmer, P. M. Aries, K. Balzer, P. Berlit, T. A. Bley, F. Buttgereit, M. Czihal, C. Dechant, C. Dejaco, U. Garske, J. Henes, J. U. Holle, K. Holl-Ulrich, P. Lamprecht, B. Nölle, F. Moosig, J. Rech, K. Scheuermann, M. Schmalzing, W. A. Schmidt, M. Schneider, H. Schulze-Koops, N. Venhoff, P. M. Villiger, T. Witte, M. Zänker & B. Hellmich. (2020) S2k-Leitlinie: Management der GroßgefäßvaskulitidenS2k guidelines: management of large-vessel vasculitis. Zeitschrift für Rheumatologie 79:S3, pages 67-95.
Crossref
Crossref
Andrew Porter & Justin C. Mason. (2020) Intervention in Takayasu Aortitis: When, Where and How?. Hearts 1:2, pages 62-74.
Crossref
Crossref
Thomas J Breen, Thomas G Osborn & Jennifer Kleinman Sween. (2020) Untreated Takayasu arteritis: an unusual case of widespread disease. BMJ Case Reports 13:8, pages e234825.
Crossref
Crossref
Corrado Campochiaro, Alessandro Tomelleri, Silvia Sartorelli, Giulio Cavalli, Giacomo De Luca, Elena Baldissera & Lorenzo Dagna. (2020) Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis. Seminars in Arthritis and Rheumatism 50:3, pages 509-514.
Crossref
Crossref
Xiao-Min Dai, Meng-Meng Yin, Yun Liu, Li-Li Ma, Jun YingLin-Di Jiang. (2020) Advancements in medical and surgical treatments of Takayasu arteritis-induced renal arteritis: a systematic review. Chinese Medical Journal 133:8, pages 975-981.
Crossref
Crossref
Xiaomeng Cui, Xiaomin Dai, Lili Ma, Chengde Yang, Wenfeng Tan, Liyun Zhang, Zhenchun Zhang, Xuebing Feng, Rui Wu, Yaohong Zou, Zhenyuan Zhou, Yu Lu, Youlian Wang, Min Wu, Supin Li, Ling Wang, He Lin, Zhihui Dong, Weiguo Fu, Xiaoning Sun, Chunsheng Wang, Jing Ding, Peng Lv, Jiang Lin & Lindi Jiang. (2020) Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort. Seminars in Arthritis and Rheumatism 50:1, pages 59-65.
Crossref
Crossref
Chunling Wu, Ying Sun, Xiaomeng Cui, Sifan Wu, Lili Ma, Huiyong Chen, Yan Yan, Zongfei Ji, Yun Liu, Jiang Lin, Peng Lv, Rongyi Chen, Pingting Yang & Lindi Jiang. (2020)
Effectiveness and safety of methotrexate
versus
leflunomide in 12-month treatment for Takayasu arteritis
. Therapeutic Advances in Chronic Disease 11, pages 204062232097523.
Crossref
Crossref
Xiaomin Dai, Xiaomeng Cui, Ying Sun, Lili Ma & Lindi Jiang. (2020) Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu’s arteritis: an observational study. Therapeutic Advances in Chronic Disease 11, pages 204062232092201.
Crossref
Crossref
Sun Ying, Cui Xiaomeng, Dai Xiaomin, Lin Jiang, Lv Peng, Ma Lili, Chen Rongyi, Ji Zongfei, Chen Huiyong & Jiang Lindi. (2020)
Efficacy and safety of leflunomide
versus
cyclophosphamide for initial-onset Takayasu arteritis: a prospective cohort study
. Therapeutic Advances in Musculoskeletal Disease 12, pages 1759720X2093011.
Crossref
Crossref
David S. Younger. (2019) Treatment of Vasculitis of the Nervous System. Neurologic Clinics 37:2, pages 399-423.
Crossref
Crossref
Ruchika Goel, T. Sathish Kumar & Debashish Danda. (2019) Childhood-Onset Takayasu Arteritis (c-TA): Current and Future Drug Therapy. Pediatric Drugs 21:2, pages 81-93.
Crossref
Crossref
Dominika Podgórska, Rafał Podgórski, David Aebisher & Piotr Dąbrowski. (2019) Takayasu arteritis - epidemiology, pathogenesis, diagnosis and treatment. Journal of Applied Biomedicine 17:1, pages 20-20.
Crossref
Crossref
M. O. Becker, B. Maurer & O. Distler. (2019) Therapiestrategien bei systemischen VaskulitidenTreatment strategies in systemic vasculitis. Gefässchirurgie 24:2, pages 152-161.
Crossref
Crossref
Enrico Tombetti & Justin C Mason. (2019) Takayasu arteritis: advanced understanding is leading to new horizons. Rheumatology 58:2, pages 206-219.
Crossref
Crossref
Alojzija Hočevar, Rok Ješe, Žiga Rotar & Matija Tomšič. (2018) Does leflunomide have a role in giant cell arteritis? An open-label study. Clinical Rheumatology 38:2, pages 291-296.
Crossref
Crossref
Durga Prasanna Misra, Anupam Wakhlu, Vikas Agarwal & Debashish Danda. (2019) Recent advances in the management of Takayasu arteritis. International Journal of Rheumatic Diseases 22, pages 60-68.
Crossref
Crossref
Michael E. Christiansen, Cumara B. O’Carroll, Gyanendra Kumar, Brandon T. Larsen & Oana M. Dumitrascu. (2019) Transcranial Doppler Evaluation in Takayasu Arteritis With Oculo-Cerebrovascular Complications. The Neurologist 24:1, pages 17-21.
Crossref
Crossref
Traci N. Adams, Da Zhang, Kiran Batra & John E. Fitzgerald. (2018) Pulmonary manifestations of large, medium, and variable vessel vasculitis. Respiratory Medicine 145, pages 182-191.
Crossref
Crossref
Eun Hye Park, Eun Young Lee & Yeong Wook Song. (2018) Takayasu Arteritis: Update on Monitoring of Disease Activity and Management. The Korean Journal of Medicine 93:5, pages 430-438.
Crossref
Crossref
Ying Sun, Lili Ma, Huiyong Chen, Xiufang Kong, Peng Lv, Xiaomin Dai, Zongfei Ji, Chengde Yang, Shengming Dai, Lijun Wu, Yaohong Zou, Jiang Lin, Hongcheng Shi, Qiang Yu & Lindi Jiang. (2018) Analysis of predictive factors for treatment resistance and disease relapse in Takayasu’s arteritis. Clinical Rheumatology 37:10, pages 2789-2795.
Crossref
Crossref
Ricardo A. G. Russo & María M. Katsicas. (2018) Takayasu Arteritis. Frontiers in Pediatrics 6.
Crossref
Crossref
Tanaz A Kermani & Bhaskar Dasgupta. (2018) Current and emerging therapies in large-vessel vasculitis. Rheumatology 57:9, pages 1513-1524.
Crossref
Crossref
Lillian Barra, Grace Yang & Christian Pagnoux. (2018) Non-glucocorticoid drugs for the treatment of Takayasu's arteritis: A systematic review and meta-analysis. Autoimmunity Reviews 17:7, pages 683-693.
Crossref
Crossref
Esther S H Kim & Joshua Beckman. (2018) Takayasu arteritis: challenges in diagnosis and management. Heart 104:7, pages 558-565.
Crossref
Crossref
Ying Sun, Lili Ma, Lingying Ma, Xiufang Kong, Huiyong Chen, Peng Lv, Jiang Lin, Hao Liu, Yan Yan, Zongfei Ji, Chengde Yang, Shengming Dai, Weiguo Wan, Yaohong Zou, Xuejuan Jin & Lindi Jiang. (2017) Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu’s arteritis. Rheumatology International 37:12, pages 2019-2026.
Crossref
Crossref
Rafael L. Pacheco, Carolina de Oliveira Cruz Latorraca, Alexandre Wagner Silva de Souza, Daniela V. Pachito & Rachel Riera. (2017) Clinical interventions for Takayasu arteritis: A systematic review. International Journal of Clinical Practice 71:11, pages e12993.
Crossref
Crossref
GSRSNK Naidu, Durga Prasanna Misra & Aman Sharma. (2017) Current and Future Treatment Options for Takayasu Arteritis and Persistent Therapeutic Challenges. Current Treatment Options in Rheumatology 3:3, pages 141-152.
Crossref
Crossref
Gokhan Keser & Kenan Aksu. (2017) What is new in management of Takayasu arteritis?. La Presse Médicale 46:7-8, pages e229-e235.
Crossref
Crossref
Durga Prasanna Misra, Aman Sharma, Tamilarasu Kadhiravan & Vir Singh Negi. (2017) A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of large vessel vasculitis. Autoimmunity Reviews 16:2, pages 179-191.
Crossref
Crossref
Raffaele Serra, Lucia Butrico, Francesco Fugetto, Mariia Dmitrievna Chibireva, Alberto Malva, Giovanni De Caridi, Mafalda Massara, Andrea Barbetta, Marco Cannistrà & Stefano de Franciscis. (2016) Updates in Pathophysiology, Diagnosis and Management of Takayasu Arteritis. Annals of Vascular Surgery 35, pages 210-225.
Crossref
Crossref
Alexandre Wagner Silva de Souza, Renan de Almeida Agustinelli, Hemerli de Cinque Almeida, Patrícia Bermudes Oliveira, Frederico Augusto Gurgel Pinheiro, Ana Cecilia Diniz Oliveira & Emilia Inoue Sato. (2016) Leflunomide in Takayasu arteritis – A long term observational study. Revista Brasileira de Reumatologia (English Edition) 56:4, pages 371-375.
Crossref
Crossref
Alexandre Wagner Silva de Souza, Renan de Almeida Agustinelli, Hemerli de Cinque Almeida, Patrícia Bermudes Oliveira, Frederico Augusto Gurgel Pinheiro, Ana Cecilia Diniz Oliveira & Emilia Inoue Sato. (2016) Leflunomida na arterite de Takayasu – Estudo observacional de longo prazo. Revista Brasileira de Reumatologia 56:4, pages 371-375.
Crossref
Crossref
Lorraine O'Neill, Cristina Ponte, Jan Sznajd, Anna P. Rodrigues, Benjamin Seeliger & Raashid A. Luqmani. (2015) Giant Cell Arteritis and Takayasu Arteritis: Are they a different spectrum of the same disease?. Indian Journal of Rheumatology 10, pages S11-S21.
Crossref
Crossref
C Ryan, A Barbour, L Burke & M N Sheppard. (2015) Non-infectious aortitis of the ascending aorta: a histological and clinical correlation of 71 cases including overlap with medial degeneration and atheroma—a challenge for the pathologist. Journal of Clinical Pathology 68:11, pages 898-904.
Crossref
Crossref
Fatma Alibaz-Oner & Haner Direskeneli. (2015) Update on Takayasu's arteritis. La Presse Médicale 44:6, pages e259-e265.
Crossref
Crossref
Boulos Haraoui. 2015. Rheumatology. Rheumatology
451
458
.
Alessandro Della Corte, Marianna Buonocore & Ciro Bancone. 2015. Pharmacotherapy in Aortic Disease. Pharmacotherapy in Aortic Disease
65
120
.
Soumya Patnaik & Amar Narayan Patnaik. (2014) Emerging drug therapies for refractory Takayasu arteritis. Journal of Indian College of Cardiology 4:4, pages 218-221.
Crossref
Crossref
Soumya Chatterjee, Scott D. Flamm, Carmela D. Tan & E. Rene Rodriguez. (2014) Clinical Diagnosis and Management of Large Vessel Vasculitis: Takayasu Arteritis. Current Cardiology Reports 16:7.
Crossref
Crossref
G. Keser, H. Direskeneli & K. Aksu. (2013) Management of Takayasu arteritis: a systematic review. Rheumatology 53:5, pages 793-801.
Crossref
Crossref
G. Masclee. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
119
137
.
Barbara A. Greco & Leslie T. Cooper. 2014. Renal Vascular Disease. Renal Vascular Disease
39
67
.
P. I. Novikov, I. O. Smitienko & S. V. Moiseev. (2013) Tumor necrosis factor alpha inhibitors in patients with Takayasu's arteritis refractory to standard immunosuppressive treatment: cases series and review of the literature. Clinical Rheumatology 32:12, pages 1827-1832.
Crossref
Crossref
Erasmia Broussalis, Eugen Trinka, Jörg Kraus, Mark McCoy & Monika Killer. (2013) Treatment strategies for vasculitis that affects the nervous system. Drug Discovery Today 18:17-18, pages 818-835.
Crossref
Crossref
Fatma Alibaz-Oner, Sibel Zehra Aydin & Haner Direskeneli. (2012) Advances in the diagnosis, assessment and outcome of Takayasu’s arteritis. Clinical Rheumatology 32:5, pages 541-546.
Crossref
Crossref
A. Turrión Nieves, A. Movasat Hajkhan & M. Álvarez-Mon Soto. (2013) Vasculitis. Arteritis de grandes arterias. Enfermedad de Behçet. Enfermedad de Kawasaki. Medicine - Programa de Formación Médica Continuada Acreditado 11:33, pages 2029-2039.
Crossref
Crossref
Andreas P. Diamantopoulos, Helene Hetland & Geirmund Myklebust. (2013) Leflunomide as a Corticosteroid-Sparing Agent in Giant Cell Arteritis and Polymyalgia Rheumatica: A Case Series. BioMed Research International 2013, pages 1-3.
Crossref
Crossref
Sebastian Unizony, John H. Stone & James R. Stone. (2013) New treatment strategies in large-vessel vasculitis. Current Opinion in Rheumatology 25:1, pages 3-9.
Crossref
Crossref